These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29273228)

  • 1. Utility of apparent diffusion coefficient as an imaging biomarker for assessing the proliferative potential of invasive ductal breast cancer.
    Zhuang Z; Zhang Q; Zhang D; Cheng F; Suo S; Geng X; Hua J; Xu J
    Clin Radiol; 2018 May; 73(5):473-478. PubMed ID: 29273228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
    Kim EJ; Kim SH; Park GE; Kang BJ; Song BJ; Kim YJ; Lee D; Ahn H; Kim I; Son YH; Grimm R
    J Magn Reson Imaging; 2015 Dec; 42(6):1666-78. PubMed ID: 25919239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
    Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
    Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any relationship between adc values of diffusion-weighted imaging and the histopathological prognostic factors of invasive ductal carcinoma?
    Aydin H; Guner B; Esen Bostanci I; Bulut ZM; Aribas BK; Dogan L; Gulcelik MA
    Br J Radiol; 2018 Apr; 91(1084):20170705. PubMed ID: 29299933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index.
    Mori N; Ota H; Mugikura S; Takasawa C; Ishida T; Watanabe G; Tada H; Watanabe M; Takase K; Takahashi S
    Radiology; 2015 Jan; 274(1):66-73. PubMed ID: 25203132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
    Suo S; Zhang D; Cheng F; Cao M; Hua J; Lu J; Xu J
    Eur Radiol; 2019 Mar; 29(3):1425-1434. PubMed ID: 30116958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated PET/MR mammography for quantitative analysis and correlation to prognostic factors of invasive ductal carcinoma.
    Kong E; Chun KA; Bae YK; Cho IH
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):118-126. PubMed ID: 26784940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent diffusion coefficient as a potential surrogate marker for Ki-67 index in mucinous breast carcinoma.
    Onishi N; Kanao S; Kataoka M; Iima M; Sakaguchi R; Kawai M; Kataoka TR; Mikami Y; Toi M; Togashi K
    J Magn Reson Imaging; 2015 Mar; 41(3):610-5. PubMed ID: 24590513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole Volume Apparent Diffusion Coefficient (ADC) Histogram as a Quantitative Imaging Biomarker to Differentiate Breast Lesions: Correlation with the Ki-67 Proliferation Index.
    Guo Y; Kong QC; Li LQ; Tang WJ; Zhang WL; Ning GY; Xue J; Zhou QW; Liang YY; Wu M; Jiang XQ
    Biomed Res Int; 2021; 2021():4970265. PubMed ID: 34258262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla.
    Park SH; Choi HY; Hahn SY
    J Magn Reson Imaging; 2015 Jan; 41(1):175-82. PubMed ID: 24353241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
    Kim SY; Kim EK; Moon HJ; Yoon JH; Koo JS; Kim SG; Kim MJ
    Magn Reson Imaging; 2018 Dec; 54():176-182. PubMed ID: 30172938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
    Shin JK; Kim JY
    J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ.
    Bickel H; Pinker-Domenig K; Bogner W; Spick C; Bagó-Horváth Z; Weber M; Helbich T; Baltzer P
    Invest Radiol; 2015 Feb; 50(2):95-100. PubMed ID: 25333308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of ductal carcinoma in situ using whole-lesion histogram analysis of the apparent diffusion coefficient.
    Kim JY; Kim JJ; Lee JW; Lee NK; Lee G; Kang T; Park H; Son YH; Grimm R
    Eur Radiol; 2019 Feb; 29(2):485-493. PubMed ID: 30073498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Different ADC Fractions, Cell Count, Ki-67, Total Nucleic Areas and Average Nucleic Areas in Meningothelial Meningiomas.
    Surov A; Caysa H; Wienke A; Spielmann RP; Fiedler E
    Anticancer Res; 2015 Dec; 35(12):6841-6. PubMed ID: 26637905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of brain metastases originating from lung and breast cancers using apparent diffusion coefficient histogram analysis and the relation of histogram parameters with Ki-67.
    Bozdağ M; Er A; Ekmekçi S
    Neuroradiol J; 2022 Jun; 35(3):370-377. PubMed ID: 34609916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.
    Thakur SB; Durando M; Milans S; Cho GY; Gennaro L; Sutton EJ; Giri D; Morris EA
    J Magn Reson Imaging; 2018 Feb; 47(2):401-409. PubMed ID: 28640531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B; Pourbagher A; Torun N
    J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.
    Catalano OA; Horn GL; Signore A; Iannace C; Lepore M; Vangel M; Luongo A; Catalano M; Lehman C; Salvatore M; Soricelli A; Catana C; Mahmood U; Rosen BR
    Br J Cancer; 2017 Mar; 116(7):893-902. PubMed ID: 28208155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.